[From the COX-concept (Cyclooxygenase-2) to clinical gain. Meloxicam sets the standard. World-wide interactive video conference, London, 26 September 1997].
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D051546:Cyclooxygenase 2; D006801:Humans; D007527:Isoenzymes / Q000494:pharmacology / Q000627:therapeutic use*; D000077239:Meloxicam; D008565:Membrane Proteins; D010544:Peroxidases / Q000494:pharmacology / Q000627:therapeutic use*; D011451:Prostaglandin-Endoperoxide Synthases / Q000494:pharmacology / Q000627:therapeutic use*; D013843:Thiazines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007527:Isoenzymes; D008565:Membrane Proteins; D013843:Thiazines; D013844:Thiazoles; D010544:Peroxidases; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D000077239:Meloxicam
Vom COX-Konzept zum klinischen Nutzen. Meloxicam setzt Massstäbe. Worldwide Interactive Videoconference London, 26. September 1997.